Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
When time is of the essence, knowing ways to get emergency cash quickly can make a difference. Explore your options.
23,900 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Peloton stock popped today as traders weighed potential index moves and improving momentum. This guide breaks down th...
Two popular aerospace ETFs, XAR and ITA, offer different paths to exposure in a sector shaped by defense spending and...
NVIDIA’s latest announcements are stirring chatter about AI-driven growth and new catalysts. Here’s what investors sh...
Meta Platforms trades near the $630s as investors weigh AI-driven capex against margin gains. A growing capital bill ...
As defense spending surging reshapes markets, two ETFs—MISL and ITA—offer different paths to ride the trend. This gui...
Two Roundhill ETFs harness a 0DTE covered call strategy to deliver regular Friday payouts, but investors should weigh...
Analysts weigh a path to $400 per share by 2028 as Apple rides iPhone demand and Services expansion, even as market h...
Costco delivered solid quarterly momentum with rising membership revenue, but the stock remains elevated on a high mu...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
When the Fed paused, a 72-year-old retired investor moved money from stocks to Treasuries for stability. The plan loo...
As July opens, traders are eyeing a quiet market mover. This unheralded sector sure has a track record of supporting ...